Tech Company Financing Transactions
Kiyatec Funding Round
Esperante BV participated in a funding round for Kiyatec. The financing round was announced on 1/9/2020.
Transaction Overview
Company Name
Announced On
1/9/2020
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Esperante BV (Dean Slagel)
Proceeds Purpose
Investment funds will be used primarily to support KIYATEC's pivotal 3D-PREDICT study (NCT03561207), designed to validate clinical assays that predict pre-treatment response to cancer drug therapies for ovarian cancer and glioblastoma.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
900-B West Faris Rd.
Greenville, SC 29605
USA
Greenville, SC 29605
USA
Phone
Website
Email Address
Overview
Guided by the company's underlying principle of renewing life through advanced technology, KIYATEC personnel work to deliver enabling 3D cell culture tools for the pharmaceutical, biomedical and life science industries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Gevaert
Chief Operating Officer
Lillia Holmes
Chief Scientific Officer
Tessa DesRochers
VP - Operations
Timothy Decker
VP - Regulatory Affairs
Cecile Vibat
Browse more venture capital transactions:
Prev: 1/9/2020: Airway Therapeutics venture capital transaction
Next: 1/9/2020: Indigo Ag venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs